Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00425165
First received: January 19, 2007
Last updated: March 17, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 31, 2011